Np mrd loader

Record Information
Version1.0
Created at2022-09-09 16:00:28 UTC
Updated at2022-09-09 16:00:28 UTC
NP-MRD IDNP0287102
Secondary Accession NumbersNone
Natural Product Identification
Common Name(2s,3s,4r,6r,8s)-4-chloro-3-ethenyl-2-isothiocyanato-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]hexadeca-1(14),11(15),12-triene-9,16-dione
Description(2S,3S,4R,6R,8S)-4-chloro-3-ethenyl-2-isothiocyanato-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]Hexadeca-1(15),11,13-triene-9,16-dione belongs to the class of organic compounds known as indoles and derivatives. These are organic compounds containing an indole, which is a bicyclic ring system made up of a six-membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring. It was first documented in 2022 (PMID: 36113990). Based on a literature review a significant number of articles have been published on (2S,3S,4R,6R,8S)-4-chloro-3-ethenyl-2-isothiocyanato-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]Hexadeca-1(15),11,13-triene-9,16-dione (PMID: 36113989) (PMID: 36113988) (PMID: 36113987) (PMID: 36113986) (PMID: 36113984) (PMID: 36113985).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC22H23ClN2O2S
Average Mass414.9500 Da
Monoisotopic Mass414.11688 Da
IUPAC Name(2S,3S,4R,6R,8S)-4-chloro-3-ethenyl-2-isothiocyanato-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1^{2,6}.0^{11,15}]hexadeca-1(15),11,13-triene-9,16-dione
Traditional Name(2S,3S,4R,6R,8S)-4-chloro-3-ethenyl-2-isothiocyanato-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1^{2,6}.0^{11,15}]hexadeca-1(15),11,13-triene-9,16-dione
CAS Registry NumberNot Available
SMILES
CN1C(=O)[C@@H]2C3=C1C=CC=C3[C@@]1(N=C=S)C(=O)[C@H](C[C@@H](Cl)[C@@]1(C)C=C)C2(C)C
InChI Identifier
InChI=1S/C22H23ClN2O2S/c1-6-21(4)15(23)10-13-18(26)22(21,24-11-28)12-8-7-9-14-16(12)17(20(13,2)3)19(27)25(14)5/h6-9,13,15,17H,1,10H2,2-5H3/t13-,15+,17-,21+,22+/m0/s1
InChI KeyRBPIZRWOMRMEOB-ADDAZVEVSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of OriginNot Available
Chemical Taxonomy
Description Belongs to the class of organic compounds known as indoles and derivatives. These are organic compounds containing an indole, which is a bicyclic ring system made up of a six-membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassIndoles and derivatives
Sub ClassNot Available
Direct ParentIndoles and derivatives
Alternative Parents
Substituents
  • Indole or derivatives
  • Benzenoid
  • Tertiary carboxylic acid amide
  • Carboxamide group
  • Isothiocyanate
  • Ketone
  • Lactam
  • Carboxylic acid derivative
  • Azacycle
  • Organic 1,3-dipolar compound
  • Propargyl-type 1,3-dipolar organic compound
  • Organooxygen compound
  • Organonitrogen compound
  • Organochloride
  • Organohalogen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organic oxygen compound
  • Alkyl chloride
  • Organic nitrogen compound
  • Organosulfur compound
  • Alkyl halide
  • Carbonyl group
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP4.74ChemAxon
pKa (Strongest Acidic)12.14ChemAxon
pKa (Strongest Basic)-3.4ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area49.74 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity113.88 m³·mol⁻¹ChemAxon
Polarizability42.62 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID78440668
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound139588580
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Concha-Miranda M, Tang W, Hartmann K, Brecht M: Large-scale mapping of vocalization-related activity in the functionally diverse nuclei in rat posterior brainstem. J Neurosci. 2022 Sep 16. pii: JNEUROSCI.0813-22.2022. doi: 10.1523/JNEUROSCI.0813-22.2022. [PubMed:36113990 ]
  2. Kausto J, Gluschkoff K, Turunen J, Selinheimo S, Peutere L, Vaananen A: Psychotherapy and change in mental health-related work disability: a prospective Finnish population-level register-based study with a quasi-experimental design. J Epidemiol Community Health. 2022 Sep 16. pii: jech-2022-218941. doi: 10.1136/jech-2022-218941. [PubMed:36113989 ]
  3. Meulemans L, Baert Desurmont S, Waill MC, Castelain G, Killian A, Hauchard J, Frebourg T, Coulet F, Martins A, Muleris M, Gaildrat P: Comprehensive RNA and protein functional assessments contribute to the clinical interpretation of MSH2 variants causing in-frame splicing alterations. J Med Genet. 2022 Sep 16. pii: jmg-2022-108576. doi: 10.1136/jmg-2022-108576. [PubMed:36113988 ]
  4. Otsuji S, Nishio Y, Tsujita M, Rio M, Huber C, Anton-Plagaro C, Mizuno S, Kawano Y, Miyatake S, Simon M, van Binsbergen E, van Jaarsveld RH, Matsumoto N, Cormier-Daire V, J Cullen P, Saitoh S, Kato K: Clinical diversity and molecular mechanism of VPS35L-associated Ritscher-Schinzel syndrome. J Med Genet. 2022 Sep 16. pii: jmg-2022-108602. doi: 10.1136/jmg-2022-108602. [PubMed:36113987 ]
  5. Crul M, Breukels O: Safe handling of cytostatic drugs: recommendations from independent science. Eur J Hosp Pharm. 2022 Sep 16. pii: ejhpharm-2022-003469. doi: 10.1136/ejhpharm-2022-003469. [PubMed:36113986 ]
  6. Kroshus E, Chrisman SPD, Glang A, Hunt T, Hays R, Lowry S, Peterson A, Garrett K, Ramshaw D, Hafferty K, Kinney E, Manzueta M, Steiner MK, Bollinger BJ, Chiampas G, Rivara FP: Concussion education for youth athletes using Pre-Game Safety Huddles: a cluster-randomised controlled trial. Inj Prev. 2022 Sep 16. pii: ip-2022-044665. doi: 10.1136/ip-2022-044665. [PubMed:36113984 ]
  7. Hwang J, Kelz R: Impact of medical education on patient safety: finding the signal through the noise. BMJ Qual Saf. 2022 Sep 16. pii: bmjqs-2022-015054. doi: 10.1136/bmjqs-2022-015054. [PubMed:36113985 ]
  8. Munoz J, Palacios-Corella M, Gomez IJ, Zajickova L, Pumera M: Synthetic Nanoarchitectonics of Functional Organic-Inorganic 2D Germanane Heterostructures via Click Chemistry. Adv Mater. 2022 Sep 16:e2206382. doi: 10.1002/adma.202206382. [PubMed:36113982 ]
  9. Adolph TE, Zhang J: Diet fuelling inflammatory bowel diseases: preclinical and clinical concepts. Gut. 2022 Sep 16. pii: gutjnl-2021-326575. doi: 10.1136/gutjnl-2021-326575. [PubMed:36113981 ]
  10. Kulkarni AV, Metage CS, Gora BA, Tirumalle S, Rakam K, Satyavadi A, Sharma M, Shaik S, Gujjarlapudi D, Rao PN, Reddy DN: SARS-CoV-2 Omicron variant infection was associated with higher morbidity in patients with cirrhosis. Gut. 2022 Sep 16. pii: gutjnl-2022-328451. doi: 10.1136/gutjnl-2022-328451. [PubMed:36113980 ]
  11. Rugge M, Genta RM, Malfertheiner P, Graham DY: Steps forward in understanding gastric cancer risk. Gut. 2022 Sep 16. pii: gutjnl-2022-328514. doi: 10.1136/gutjnl-2022-328514. [PubMed:36113979 ]
  12. Rees CJ, Hamilton W: BSG guidelines on faecal immunochemical testing: are they 'FIT' for purpose? Gut. 2022 Sep 16. pii: gutjnl-2022-328201. doi: 10.1136/gutjnl-2022-328201. [PubMed:36113978 ]
  13. Zhang Q, Mao Y, Lin C, Hu M, Wang Y, Lou Y, Kong Q, Zhang J, Li J, Zhang Y, Yang T, Sun X, Yao W, Hua Y, Huang H, Xu M, Wang X, Yu X, Tao W, Liu R, Gao Y, Wang T, Wang J, Wei X, Wu J, Yu Z, Zhang C, Yu C, Bai X, Liang T: Mass cytometry-based peripheral blood analysis as a novel tool for early detection of solid tumours: a multicentre study. Gut. 2022 Sep 16. pii: gutjnl-2022-327496. doi: 10.1136/gutjnl-2022-327496. [PubMed:36113977 ]
  14. Toresdahl BG, Metzl JD, Kinderknecht J, McElheny K, de Mille P, Quijano B, Fontana MA: Training patterns associated with injury in New York City Marathon runners. Br J Sports Med. 2022 Sep 16. pii: bjsports-2022-105670. doi: 10.1136/bjsports-2022-105670. [PubMed:36113976 ]
  15. Recchia F, Leung CK, Chin EC, Fong DY, Montero D, Cheng CP, Yau SY, Siu PM: Comparative effectiveness of exercise, antidepressants and their combination in treating non-severe depression: a systematic review and network meta-analysis of randomised controlled trials. Br J Sports Med. 2022 Sep 16. pii: bjsports-2022-105964. doi: 10.1136/bjsports-2022-105964. [PubMed:36113975 ]
  16. Shimada S, Ikenoue C, Iwashita Y, Miyamoto T: Contributions of the Tokyo 2020 Infectious Diseases Control Centre in curbing SARS-CoV-2 spread during the Olympic and Paralympic Games. Br J Sports Med. 2022 Sep 16. pii: bjsports-2022-105691. doi: 10.1136/bjsports-2022-105691. [PubMed:36113974 ]
  17. Urhausen AP, Berg B, Oiestad BE, Whittaker JL, Culvenor AG, Crossley KM, Juhl CB, Risberg MA: Measurement properties for muscle strength tests following anterior cruciate ligament and/or meniscus injury: What tests to use and where do we need to go? A systematic review with meta-analyses for the OPTIKNEE consensus. Br J Sports Med. 2022 Sep 16. pii: bjsports-2022-105498. doi: 10.1136/bjsports-2022-105498. [PubMed:36113973 ]
  18. Neves J, Al-Harahsheh ST, Swart K, Shaban S, Hudaib A: Inclusion of persons with disability in sport: part 2 - best practices and policy recommendations from Qatar. Br J Sports Med. 2022 Nov;56(22):1259-1260. doi: 10.1136/bjsports-2022-106225. Epub 2022 Sep 16. [PubMed:36113972 ]
  19. Al-Harahsheh ST, Swart K, Neves J, Shaban S: Inclusion of persons with disability in sport: part 1 - rights and challenges in Qatar. Br J Sports Med. 2022 Nov;56(22):1257-1258. doi: 10.1136/bjsports-2022-106224. Epub 2022 Sep 16. [PubMed:36113971 ]
  20. Jimenez IA, Pool RR, Gabrielson KL: Canine Idiopathic Arteriopathy, Appendicular Bone Infarcts, and Neoplastic Transformation of Bone Infarcts in 108 Dogs (Canis lupus familiaris). Comp Med. 2022 Oct 1;72(5):306-319. doi: 10.30802/AALAS-CM-22-000037. Epub 2022 Sep 16. [PubMed:36113969 ]
  21. LOTUS database [Link]